About: ProQR

An Entity of Type: Public company, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org:8891

ProQR Therapeutics NV (NASDAQ: PRQR) is a Dutch biotechnology company based in Leiden, the Netherlands. The company was funded in 2012 by chief executive officer (CEO) Daniel de Boer. It specializes in the development of RNA therapeutics for rare genetic diseases with an ophthalmologic application.

Property Value
dbo:abstract
  • ProQR Therapeutics NV (NASDAQ: PRQR) es una empresa holandesa, especializada en el desarrollo de fármacos de ARN contra enfermedades raras. Fue fundada en 2012 y está basada en Leiden, en los Países Bajos. (es)
  • ProQR Therapeutics NV (NASDAQ: PRQR) is a Dutch biotechnology company based in Leiden, the Netherlands. The company was funded in 2012 by chief executive officer (CEO) Daniel de Boer. It specializes in the development of RNA therapeutics for rare genetic diseases with an ophthalmologic application. (en)
  • ProQR Therapeutics NV (NASDAQ: PRQR) is een Nederlands biotechnologisch bedrijf gespecialiseerd in het ontwikkelen van op RNA gebaseerde geneesmiddelen voor de bestrijding van genetische ziekten. Het bedrijf is opgericht in 2012 in Leiden, Nederland. (nl)
dbo:foundingYear
  • 2012-01-01 (xsd:gYear)
dbo:keyPerson
dbo:locationCity
dbo:numberOfEmployees
  • 150 (xsd:nonNegativeInteger)
dbo:product
dbo:thumbnail
dbo:type
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 57673641 (xsd:integer)
dbo:wikiPageLength
  • 7776 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1073019279 (xsd:integer)
dbo:wikiPageWikiLink
dbp:founded
  • 2012 (xsd:integer)
dbp:hqLocationCity
dbp:industry
  • Biotechnology Pharmaceuticals (en)
dbp:keyPeople
  • Daniel de Boer (en)
dbp:logo
  • ProQR logo.jpg (en)
dbp:name
  • ProQR (en)
dbp:numEmployees
  • 150 (xsd:integer)
  • (en)
dbp:products
dbp:tradedAs
  • NASDAQ:PRQR (en)
dbp:type
dbp:website
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • ProQR Therapeutics NV (NASDAQ: PRQR) es una empresa holandesa, especializada en el desarrollo de fármacos de ARN contra enfermedades raras. Fue fundada en 2012 y está basada en Leiden, en los Países Bajos. (es)
  • ProQR Therapeutics NV (NASDAQ: PRQR) is a Dutch biotechnology company based in Leiden, the Netherlands. The company was funded in 2012 by chief executive officer (CEO) Daniel de Boer. It specializes in the development of RNA therapeutics for rare genetic diseases with an ophthalmologic application. (en)
  • ProQR Therapeutics NV (NASDAQ: PRQR) is een Nederlands biotechnologisch bedrijf gespecialiseerd in het ontwikkelen van op RNA gebaseerde geneesmiddelen voor de bestrijding van genetische ziekten. Het bedrijf is opgericht in 2012 in Leiden, Nederland. (nl)
rdfs:label
  • ProQR (es)
  • ProQR (nl)
  • ProQR (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • ProQR (en)
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License